Comparative trends in hospitalizations for osteoporotic fractures and other frequent diseases between 2000 and 2008 by Lippuner, K et al.
ORIGINAL ARTICLE
Comparative trends in hospitalizations for osteoporotic
fractures and other frequent diseases between 2000 and 2008
K. Lippuner & S. Grifone & M. Schwenkglenks &
P. Schwab & A. W. Popp & C. Senn & R. Perrelet
Received: 7 March 2011 /Accepted: 2 May 2011 /Published online: 28 May 2011
# International Osteoporosis Foundation and National Osteoporosis Foundation 2011
Abstract
Summary In Switzerland, the number, incidence, and cost
of acute hospitalizations for major osteoporotic fractures
(MOF) and major cardiovascular events (MCE) increased
in both women and men between 2000 and 2008, although
the mean length of stay (LOS) was significantly reduced.
Similar trend patterns were observed for hip fractures and
strokes (decrease) and nonhip fractures and acute myocardial
infarctions (increase).
Introduction The purpose of this study was to compare the
trends and epidemiological characteristics of hospitalizations
for MOF and other frequent diseases between years 2000 and
2008 in Switzerland.
Methods Trends in the number, age-standardized incidence,
mean LOS, and cost of hospitalized MOF and MCE (acute
myocardial infarction, stroke, and heart failure) were
compared in women and men aged ≥45 years, based on
data from the Swiss Federal Statistical Office.
Results Between 2000 and 2008, the incidence of acute
hospitalizations for MOF increased by 3.4% in women and
0.3% in men. In both sexes, a significant decrease in hip
fractures (−15.0% and −11.0%) was compensated by a
concomitant, significant increase in nonhip fractures
(+24.8% and +13.8%). Similarly, the incidence of acute
hospitalizations for MCE increased by 4.4% in women and
8.2% in men, as an aggregated result from significantly
increasing acute myocardial infarctions and significantly
decreasing strokes. While the mean LOS in the acute
inpatient setting decreased almost linearly between
years 2000 and 2008 in all indications, the inpatient
costs increased significantly (p<0.001) for MOF (+30.1%
and +42.7%) and MCE (+22.6% and +47.1%) in women
and men, respectively.
Conclusions Between years 2000 and 2008, the burden of
hospitalized osteoporotic fractures to the Swiss healthcare
system has continued to increase in both sexes. In women,
this burden was significantly higher than that of MCE and
the gap widened over time.
Keywords Acute myocardial infarction . Breast cancer .
Chronic obstructive pulmonary disease . Clinical spine
fracture . Cost . Distal radius fracture . Epidemiology . Heart
failure . Hip fracture . Osteoporosis . Proximal humerus
fracture . Stroke . Switzerland
Introduction
Osteoporotic fractures are one of the leading causes of
morbidity and mortality in industrialized countries [1].
While virtually any fracture may result as a complication
from underlying osteoporosis, “typical” osteoporotic frac-
tures occur at the hip, spine, distal forearm, and proximal
humerus. Together, they are traditionally referred to as
major osteoporotic fractures (MOF) [1–3].
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In year 2000, in all women living in Switzerland,
the overall incidence of hospitalizations for any
osteoporotic fracture was twice as high as that for
breast cancer and pooled major cardiovascular events
(MCE: acute myocardial infarction, stroke, and heart
failure) and almost three times that of chronic obstruc-
tive pulmonary disease (COPD) [4]. In Swiss men, the
overall incidence of hospitalizations for any osteoporotic
fracture was half that of pooled MCE and two thirds that
of COPD [4]. As recently published, the age-standardized
incidences of hospitalized MOF continued to increase in
Swiss women and men aged 45 years and older between
the years 2000 and 2007, driven by an increasing number
and incidence of hospitalizations for nonhip fractures,
although the number of hip fractures was on the decline
[5].
The aim of the present analysis was to compare the
trends and epidemiological characteristics, in female and
male patients aged 45 years or older, of MOF, MCE,
COPD, and breast carcinoma (women only) in Switzerland,
between the years 2000 and 2008. Predefined parameters of
interest were absolute number and incidence of hospital-
izations, number of hospital days due to fractures, and cost
of hospitalizations.
Methods
A summary of the data processing flow and relevant data
sources is shown in Fig. 1.
Selected ICD-10 codes
Diseases were selected according to the 10th Edition of
the International Classification of Diseases (ICD-10)
issued by the World Health Organization [6]. MOF were
divided into two categories: hip (ICD-10 codes S72.0
(fracture of the femoral neck), S72.1 (pertrochanteric
fracture), and S72.2 (subtrochanteric fracture)) and non-
hip. Nonhip fractures were defined as: spine fractures
coded as S22.0 (fracture of the thoracic spine), S22.1
(multiple fractures of the thoracic spine), S32.0 (fracture
of the lumbar spine), S32.7 (multiple fractures of the
lumbar spine), and S32.8 (other fractures of the lumbar
spine); fractures of the distal forearm coded as S52.5
(fracture of the distal radius) and S52.6 (combined fracture
of the distal radius/ulna); fractures of the proximal
humerus coded as S42.2 (fracture of the proximal
humerus).
MCE were defined as myocardial infarction coded as I21
(acute myocardial infarction) and I22 (subsequent myocar-
dial infarction); stroke coded as I63 (cerebral infarction),
I64 (stroke, not specified as hemorrhage or infarction), I65
(occlusion and stenosis of precerebral arteries, not resulting
in cerebral infarction), and I66 (occlusion and stenosis of
cerebral arteries, not resulting in cerebral infarction); heart
failure coded as I50 (heart failure). COPD were defined as
codes J40 (bronchitis, not specified as acute or chronic),
J41 (simple and mucopurulent chronic bronchitis), J42
(unspecified chronic bronchitis), J43 (emphysema), J44
(other COPD), J45 (asthma), J46 (status asthmaticus), and
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Fig. 1 Data sources and data
processing flow. SFSO Swiss
Federal Statistical Office, ICD
International Classification of
Diseases, COPD chronic
obstructive pulmonary diseases
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J47 (bronchiectasis). Breast carcinoma corresponded to the
ICD-10 code C50 (malignant neoplasm of breast).
Source of hospital statistics
The administrative and medical statistics database of the
Swiss Federal Statistical Office (SFSO) was used. All Swiss
acute care hospitals, rehabilitation centers, and specialized
clinics are obliged to supply their medical data to the SFSO
(age, sex, number of hospitalizations coded according to the
ICD-10 requirements, and duration of hospitalization). Data
collection is coordinated by the SFSO. Data consistency
and quality are ensured at the individual hospital, cantonal,
and federal level through the mandatory use of a plausibil-
ity testing software developed by the SFSO [7]. This
software performs more than 700 plausibility checks on
single and pooled variables, including multiple interdepen-
dent variable testing and diagnostic code vs. treatment code
testing. Inconsistencies and errors indicated in the log files
are corrected at the appropriate level (individual hospital for
source data, canton for inconsistencies across hospitals, and
confederation for inconsistencies across cantons) following
a feedback loop. This process ensures low error rates so that
the level of plausibility of the reported diagnostic codes
exceeds 95% [8]. Only medical data from Swiss acute
hospital settings were retained for the present analysis. Data
from rehabilitation centers and specialized clinics were
excluded to prevent double counting. The degree of
completeness for all records for years 2000 to 2008 was
81.2%, 84.9%, 95.0%, 94.1%, 96.2%, 98.2%, 98.5%,
98.6%, and 98.8%, respectively.
Raw data for the number of hospitalizations for the
selected ICD-10 codes and corresponding duration of hospi-
talization were obtained for women and men aged ≥45 years.
Only the primary diagnostic code, i.e., the reason for
hospitalization, was considered for each patient to prevent
double counting. All raw data were extrapolated pro rata to
100% to compensate for incomplete coverage and to become
representative for Switzerland as a whole.
Data on the Swiss population structure between 2000
and 2008, split by 10-year age groups and sex, were also
obtained from the SFSO.
Epidemiological characteristics of hospitalizations
The age-standardized incidence of hospitalizations, the
number of patient-days spent in hospital, and the mean
hospital length of stay (LOS) per patient were calculated by
10-year age groups starting from age 45 onwards and by
sex for all selected ICD-10 codes grouped into the
categories defined above. Annual crude incidences and
95% confidence intervals per 100,000 persons in years 2000
to 2008 were calculated by sex and 10-year age groups
starting from age 45 onwards. Annual age-standardized
incidences per 100,000 persons and 95% confidence
intervals were calculated by sex based on 10-year age
groups and adjusted for the age structure of the Swiss
population in year 2000 according to a method published
earlier [9]. Standardized incidence rate ratios and 95%
confidence intervals were calculated to assess the change in
incidence over time. As the goodness-of-fit of tentative
Poisson regression models could not be confirmed, related
time trends were assessed by fitting gender-specific
negative binomial models with ICD-10 code and year as
covariates.
The mean hospital LOS was estimated by dividing the
total number of patient-days spent in hospital by the
number of hospitalizations. The cost of hospitalizations
was estimated by multiplying the number of patient-days
spent in hospital by the yearly average cost of 1 day in
hospital in Swiss Francs (CHF) between 2000 and 2008.
The latter was obtained from yearly summary tables derived
from the hospital statistics database of the SFSO for each
year of analysis and was not inflation adjusted [10]. The
effects of time on mean LOS and hospitalization cost were
tested for statistical significance by the two-way analysis of
variance method. All calculations were done with the
statistical software StatsDirect version 2.7.8 (StatsDirect
Ltd., Altrincham, Cheshire, UK). Negative binomial re-
gression was performed in Stata/MP version 11.1 (Stata
Corporation, College Station, TX, USA).
Results
Swiss population structure
Between years 2000 and 2008, the number of women and
men aged 45 years and older increased by 13.3% and
17.4%, respectively.
Number of hospitalizations
Between 2000 and 2008, the absolute number of acute care
hospitalizations for MOF in patients aged ≥45 years
increased from 13,948 to 16,339 (+17.1%) in women and
from 4,670 to 5,634 (+20.6%) in men, essentially driven by
nonhip fractures (+41.3% and +34.6%, respectively)
(Fig. 2). During the same time, the number of hip fractures
decreased from 7,684 to 7,485 (−2.6%) in women and
remained stable in men (from 2,538 to 2,765, +1%).
Similarly, the number of hospitalizations for MCE in-
creased from 9,530 to 11,271 (+18.3%) and from 12,634 to
16,378 (+29.6%) in women and men, respectively. In
contrast, the number of hospitalizations for COPD de-
creased from 5,115 to 4,210 (−17.7%) and from 6,844 to
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4,934 (−27.9%) in women and men, respectively. Finally,
the number of hospitalizations for breast cancer decreased
from 9,400 to 7,650 (−18.6%) in women.
Age-standardized incidence of hospitalizations
In women, as shown in Table 1, the age-standardized
incidence of hospitalized MOF increased by 3.4% between
2000 and 2008 (p for trend, 0.121), the significant decrease
in hip fractures (−15.0%; p for trend, <0.001) being fully
compensated by a concomitant significant increase in
hospitalized nonhip fractures (+24.8%; p for trend, 0.002).
The latter resulted from an increase in hospitalized fractures
of the spine (+32.2%; p for trend, 0.008), the distal radius
(+31.8%; p for trend, 0.005), and the proximal humerus
(+10.3%, p for trend, 0.141). Similarly, the incidence of
acute hospitalizations for MCE increased by 4.4% (p for
trend, 0.558) during the observation period, as an aggre-
gated result of a significant increase in acute myocardial
infarctions (+29.5%; p for trend, 0.016) opposed by a
significant decrease in hospitalized strokes (−17.8%; p for
trend, 0.016), and with no change in the incidence of
hospitalizations for heart failure (+0.8%; p for trend,
0.926). Finally, the incidence of hospitalizations for COPD
and breast cancer decreased significantly by 27.3% (p for
trend, 0.016) and 28.2% (p for trend, <0.001), respectively.
In men, as shown in Table 1, the incidence of
hospitalized MOF did not change between 2000 and
2008 (+0.3%; p for trend, 0.918). The significant
reduction in incident hip fractures (−11.0%; p for trend,
0.031) was totally offset by a significant increase in
nonhip fractures (+13.8%; p for trend, 0.032), mainly
driven by fractures of the distal radius (+29.2%; p for
trend, <0.001) and the proximal humerus (+12.5%; p for
trend, 0.295). The incidence of acute hospitalizations for
MCE increased significantly by 8.2% (p for trend, 0.019).
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Interestingly, this overall increase resulted from an
increase in hospitalizations for myocardial infarctions
(+24.7%; p for trend, <0.001) and heart failure (+8.5%;
p for trend, 0.208) opposed by a significant reduction in
the incidence of stroke (−28.1%; p for trend, 0.006).
Finally, incident hospitalizations for COPD were signifi-
cantly reduced by 39.7% (p for trend, 0.002).
The overall pattern of changes in age-standardized
incidences was consistent across sexes: decreasing inciden-
ces of hospitalizations for hip fractures and stroke,
increasing incidences in hospitalizations for nonhip MOF
and acute myocardial infarctions, and decreasing incidence
in hospitalizations for COPD. The observed increasing or
decreasing trends in any disease category went in the same
direction and were of similar magnitude in all age groups
(Fig. 3).
Patient-days in hospital and mean length of stay
The total number of days spent during the acute hospital-
ization phase decreased almost linearly between years 2000
and 2008 in all indications of interest and in both sexes. In
women, the highest relative decrease was observed for
COPD (from 89,554 to 56,099 days, −37.4%), followed by
breast carcinoma (from 90,951 to 57,842 days, −36.4%),
MCE (from 164,685 to 124,384 days, −24.5%), and MOF
(from 224,244 to 179,461 days, −19.9%). Therefore,
hospitalization for MOF remains a major contributor of
days spent in hospital by women aged 45 years or more,
responsible for three times more days of hospitalization
than COPD and breast cancer and 1.5 times more days than
any MCE.
Inmen, the highest relative decrease in days spent in hospital
was observed for COPD (from 107,329 to 60,663, −43.5%)
followed by MOF (from 71,477 to 62,828, −12.1%) and MCE
(from 174,858 to 158,441, −9.4%). Therefore, in 2008, there
were as many days spent in hospital by men for COPD, acute
myocardial infarction (67,997 days), and heart failure
(57,822 days) as for MOF.
These considerable reductions in total days spent in
hospital for all indications of interest were essentially due
to a relevant and statistically significant reduction of the
mean LOS as shown in Table 2.
Cost of hospitalizations
As described above, the mean LOS for patients hospitalized
because of fractures decreased substantially between 2000
and 2008. The effect of this was counterbalanced, however,
by rising hospital costs: the mean cost per day of
hospitalization increased from CHF 996.00 to CHF
1,618.00 over the same period, a rise of 62%. The effects
on hospitalization costs by selected diagnostic codes are
shown in Fig. 4.
In women, hospitalization cost for MOF increased from
CHF 223 to 291 million (mio; +30.1%, p<0.001 for time
trend) and from 164 to 201 mio (+22.6%, p<0.001) for
MCE. The cost of hospitalizations for COPD and breast
cancer remained almost unchanged (from CHF 89 to 91
mio, +1.7%, p=0.168 and from 91 to 94 mio, +3.3%, p=
0.003, respectively). Overall, in women in 2008, the cost of
acute hospitalizations was more than threefold higher for
MOF than for COPD and breast cancer and 1.5-fold higher
than for any MCE. As shown in Fig. 5, osteoporotic
fractures contributed to approximately 60% of the total
costs of MOF and MCE in women.
In men, the cost of acute hospitalizations for MOF and
MCE between 2000 and 2008 increased by 42.7% (from
CHF 71 to 102 mio, p<0.001 for time trend) and by 47.1%
(from CHF 174 to 256 mio, p<0.001), respectively.
Therewhile, the cost of hospitalizations for COPD was
reduced by 8.2% (from CHF 107 to 98 mio, p=0.078).
Overall, in men in 2008, the cost of acute hospitalizations
for MOF was comparable to that of COPD, acute
myocardial infarction (CHF 110 mio), and heart failure
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(CHF 94 mio). As shown in Fig. 5, osteoporotic fractures
represented approximately 30% of the total costs of MOF
and MCE in men.
Discussion
The present analysis reports the epidemiological character-
istics of hospitalizations in the acute care setting of patients
with MOF, MCE, COPD, or breast carcinoma in Switzer-
land between years 2000 and 2008. For the first time, time
trends were established by using a nationwide database of
medical records following an identical methodology, which
ensures the highest possible homogeneity in results and
should allow for comparisons with only little potential for
bias. In this analysis, the age-standardized rates of hospital-
izations for MOF and MCE increased during the observa-
tion period, driven by an increase in nonhip fractures and
acute myocardial infarctions, respectively. In addition, the
mean hospital LOS decreased significantly in all indications
of interest, the cost effect of which was offset by the
increase in cost per day of hospitalization. Overall, the total
cost of hospitalizations, which aggregates the cost effect of
the number of hospitalizations, mean hospital LOS, and
cost per day of hospitalization, increased by 30% and 43%
for MOF and 23% and 47% for MCE in women and men,
respectively. The total cost incurred by hospitalizations for
COPD and breast cancer remained virtually unchanged.
During the same time, hospitalizations for hip fractures,
stroke, COPD, and breast cancer decreased significantly.
Reported changes followed similar patterns in both sexes,
although of different orders of magnitude.
In Swiss women, during the 9 years of observation,
osteoporosis and its complications, as measured by the
characteristics of hospitalizations for MOF, remained a key
contributor to the economic burden of healthcare. As
confirmed by the present analysis, hip fractures seem to
decline in Swiss women, which confirm earlier findings
from our group [5] and others [11, 12]. This possible
reversal of a secular trend is consistent with reports from
other countries such as USA [13–15], Canada [16, 17],
Japan [18], Finland [19], and Denmark [20]. Similar
observations were made in neighbor countries such as
France [21] and Austria [22] but not in Italy [23] and
Table 2 Changes in mean hospital LOS (days) in women and men
2000 2001 2002 2003 2004 2005 2006 2007 2008 Change 2008
vs. 2000 (%)
p value for
time effect
Women
Major osteoporotic fractures 16.1 15.0 14.6 13.8 12.9 12.2 11.5 11.4 11.0 −31.6 <0.001
Hip fractures 19.0 17.8 17.9 17.6 16.5 16.0 14.9 14.7 14.0 −26.5 <0.001
Nonhip fractures 12.4 11.5 11.0 9.9 9.4 8.8 8.7 8.6 8.5 −32.1 <0.001
Spine fractures 16.7 14.8 16.7 15.6 13.9 13.4 13.4 12.3 12.6 −24.5 <0.001
Distal radius fractures 8.7 8.3 7.0 6.2 6.3 5.7 5.5 5.6 5.4 −38.3 <0.001
Proximal humerus fractures 15.0 14.2 13.2 12.4 11.6 11.5 11.3 10.9 10.5 −30.1 <0.001
Major CV events 17.3 16.1 15.4 15.2 14.6 13.4 12.7 12.0 11.0 −36.1 <0.001
Acute MI 12.6 12.1 11.9 11.2 10.2 9.6 9.4 9.3 9.5 −24.1 <0.001
Stroke 23.7 21.6 20.7 20.7 19.8 18.2 16.7 14.8 10.7 −55.1 <0.001
Heart failure 16.4 15.6 15.2 15.0 15.0 13.8 13.4 13.1 12.7 −22.2 0.006
COPD 17.5 16.8 16.8 15.3 14.7 13.6 13.8 13.3 13.3 −23.9 <0.001
Breast carcinoma 9.7 9.2 8.9 8.7 8.2 7.7 7.7 7.6 7.6 −21.9 <0.001
Men
Major osteoporotic fractures 15.3 14.0 13.9 13.3 12.5 11.5 11.7 11.2 11.2 −27.1 <0.001
Hip fractures 18.8 17.2 17.4 16.7 15.9 15.2 15.1 14.4 13.8 −27.0 <0.001
Nonhip fractures 11.1 10.5 10.0 9.7 9.2 8.3 8.6 8.4 8.6 −22.1 <0.001
Spine fractures 13.9 13.5 13.7 12.3 11.5 10.5 11.3 10.3 11.0 −20.9 <0.001
Distal radius fractures 6.0 6.1 5.5 5.7 5.3 5.3 5.0 4.8 5.3 −12.0 0.184
Proximal humerus fractures 12.4 11.1 10.4 11.1 10.4 9.2 9.6 10.0 9.6 −23.1 0.004
Major CV events 13.8 13.1 12.0 11.7 11.4 10.5 10.2 9.8 9.7 −30.1 <0.001
Acute MI 9.4 9.3 8.6 8.2 8.0 7.5 7.4 7.3 7.5 −19.8 <0.001
Stroke 23.0 20.8 19.2 18.6 18.1 15.6 15.3 13.7 13.5 −41.3 <0.001
Heart failure 14.3 13.9 12.9 12.7 12.6 12.2 12.0 11.9 11.7 −17.7 0.225
COPD 15.7 15.7 14.4 14.4 13.6 12.9 13.0 12.5 12.3 −21.6 <0.001
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Germany [24, 25]. In contrast, the incidence of hospital-
izations for nonhip fractures steadily increased between
years 2000 and 2008 in Swiss women. This effect was
observed for all localizations of nonhip fractures (spine,
distal radius, and proximal humerus). Possible explanations
will remain speculative and were detailed elsewhere [5]. We
are not aware of other publications confirming or infirming
this observation, with the exception of earlier reports from
Finland which indicated that low-trauma knee [26], ankle
[27], and distal humeral [28] fractures may be stabilizing or
even declining in this country. Importantly, the present
analysis reports hospitalized fractures only. Whether the
total incidence of hospitalized and nonhospitalized nonhip
fractures has increased cannot be concluded from the
present data. However, as ongoing healthcare reform efforts
have led to a global shift from inpatient to outpatient care
[29], the matter deserves further investigation. The age-
standardized incidence of hospitalizations for hip and
nonhip fractures in men followed a similar pattern as in
women but with a lower magnitude of change.
Interestingly, in women, the incidence of hospitalizations
for acute myocardial infarctions increased strongly, while
they stagnated for heart failure and decreased for stroke,
with a similar pattern in men. Although a milestone
regarding the characteristics of acute coronary syndromes
in the real world was achieved already in 1997 by
launching the Acute Myocardial Infarction in Switzerland
(AMIS) and AMIS Plus registry [30], we are not aware of
previously published trend patterns for hospitalized MCE in
Switzerland. An increasing number of publications report
the association between cardiovascular diseases and osteo-
porotic fractures. Among the very first indices in this
regard, a Swedish registry collected 273,288 strokes and
24,666 fractures, of which 14,263 were hip fractures,
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between 1987 and 1996 and concluded that, after a
hospitalization for stroke, there was a more than sevenfold
increase in fracture risk during the first year after
hospitalization for stroke [31]. In 2007, Sennerby et al.
showed that women with cardiovascular disease had a
substantially increased risk of hip fracture, suggesting
possible common pathologic pathways for osteoporotic
fractures and cardiovascular diseases [32]. In addition, in
a cohort of 31,936 Swedish twins born in 1914–1944
followed up from the age of 50 years, the same authors
reported that a diagnosis of cardiovascular disease was
significantly associated with risk of subsequent hip fracture
within the same individual and in his or her co-twin without
index diagnosis [33]. In the present analysis, we report an
increasing incidence of both MOF and major cardiovascular
diseases between 2000 and 2008 in Switzerland, which is
consistent with a possible association between both disease
entities. We also report decreasing trends in hip fractures
and stroke and increasing trends in nonhip fractures and
acute myocardial infarctions, which raises the question
whether the supposed association between osteoporosis and
cardiovascular diseases might be more multifaceted than
suggested to date.
The present analysis based on data of the medical
database of the SFSO did not allow for identification of
potential underlying associations or causes for the reported
time trends. The earlier mentioned prospective AMIS Plus
registry collects 230 variables of patients hospitalized for
acute coronary syndromes in 76 Swiss hospitals participat-
ing on a voluntary basis. If a similar registry existed for
osteoporotic fractures, ideally in the same or a subset of the
AMIS hospitals, database linkages could offer a unique
opportunity for exploring further the associations between
fractures and cardiovascular diseases. Furthermore, both
fractures and MCE often lead to patient discharge to a
rehabilitation center. Here again, a fracture registry com-
bined with AMIS Plus could possibly contribute to identify
common prognostic factors and to improve outcomes.
The present analysis reports hospitalized clinical events
only. It is well known that many osteoporotic fractures are
treated in the outpatient setting. Based on data from the
Swiss nationwide survey in the OsteoCare cohort, which
included 3,667 consecutive women and men aged 50 years
and older and presenting to the emergency ward of
participating hospitals with a fragility fracture [34], virtu-
ally all hip fractures, approximately half of proximal
humerus fractures, one third of distal radius fractures, and
one fourth of clinical spine fractures were hospitalized in
Switzerland [3]. These observations are broadly consistent
with reports from other countries [35]. On the other hand,
as many as 25% of all coronary events are lethal before the
patient reaches the hospital, a proportion that continues to
increase as a result of the decline in in-hospital deaths
observed during the past decades [36]. Therefore, the
proposed comparisons across diseases should be considered
as restricted to hospitalizations only.
We reported on MOF, i.e., of a subset of all
hospitalized osteoporotic fractures. Achieving complete-
ness would have required the very cumbersome use of
osteoporosis attribution rates, as was exemplified earlier
[4, 37]. Using the present approach, MOF were estimated
to represent only 77% and 72% of attributable fractures in
women and men in year 2000, respectively [3–5].
Therefore, absolute numbers, incidences, hospital days,
and related costs reported in the analysis should be
considered conservative. Data completeness was 81.2%
and 84.9% in years 2000 and 2001, respectively, and
exceeded 95.0% thereafter. The extrapolation to 100%
could have induced a selection bias when comparing
year 2008 with 2000. However, the trends observed over
the 9 years were consistent year over year in all diseases of
interest and no outliers were identified.
Of note, the total cost estimate for osteoporotic fractures
(CHF 393 mio) reported in the present analysis refers to
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direct medical costs of acute hospitalizations for MOFs
only. The total direct medical cost of all hospitalized
osteoporotic fractures can be extrapolated to CHF 524
mio, to which the inpatient rehabilitation and nursing home
costs should be added. These represent approximately 50%
of the total cost of the inpatient management of osteopo-
rotic fractures, as already published earlier by our group
[38], so that the total cost of treating hospitalized
osteoporotic fractures in Switzerland exceeded CHF 1
billion in 2008. Cost estimates calculated in the present
analysis are based on the nationwide average real cost per
day of hospitalization and not on discipline-specific costs or
diagnosis-related groups (DRGs). Therefore, cost estimates
should be regarded as approximations, until the introduc-
tion of the DRG system will allow more precise estimates.
Finally, we did not attempt a projection based on
observed trends. According to demographic scenarios from
the SFSO, the Swiss population older than 65 years of age
will almost have doubled in 2050 [39]. Therefore, assuming
that the current time trends remain unchanged, the declining
incidence of hip fractures and strokes will not be sufficient
to reduce the absolute number of hospitalizations for these
diseases in the coming decades. A representative cohort or
a fracture registry linked to the AMIS Plus registry would
contribute to better anticipation of future trends and allow
for monitoring the effects of public health measures aimed
at reducing fracture and cardiovascular risk.
In conclusion, between years 2000 and 2008, the burden
of hospitalized osteoporotic fractures to the Swiss health-
care system has continued to increase in both sexes. In
women, this burden was significantly higher than that of
MCE and the gap between both disease groups widened
over time. More research is warranted to better understand
the causal drivers behind these trends.
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